Addressing pathogens that compromise ocular health remains a critical component of global eye care. Infectious eye diseases span bacterial, viral, fungal, and parasitic origins, often with rapid onset and potential for lasting visual impairment. Early detection and tailored antimicrobial therapy are vital in cases such as herpetic keratitis, fungal endophthalmitis, and Acanthamoeba infections. Molecular diagnostics and culture techniques continue to improve identification of rare pathogens. In high-risk areas, public health initiatives focus on preventing trachoma and onchocerciasis through antibiotics and vector control programs. Immunocompromised individuals require vigilant monitoring, as opportunistic infections can progress swiftly. Cross-disciplinary collaboration with infectious disease specialists and microbiologists enhances treatment efficacy. Increasing antimicrobial resistance is pushing researchers to develop novel therapeutics and vaccines, ensuring this evolving threat remains manageable in clinical settings.
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Management of common vitreoretinal lesions: An overview and update
Tim Jackson, King’s College London, United Kingdom
Title : Targeting immunological pathways in Behcet's uveitis
Hashim Butt, Bolton Royal Hospital, United Kingdom
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : The effect of low hypermetropia correction and office-based orthoptic training on binocular vision parameters in children with convergence insufficiency
Agnieszka Rosa, Orticus Center for the Treatment of Strabismus and Vision Disorders, Poland
Title : Evaluating the quality and readability of AI chatbot responses to frequently asked questions on basal cell carcinoma: Implications for patient education and digital health communication
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom